
Charlotte Huff
Articles
-
1 month ago |
immattersacp.org | Charlotte Huff |Gianna Melillo |ACP Internist
Screening with digital breast tomosynthesis may provide more accurate screening than digital mammography for women with a family history of breast cancer, especially if they have dense breasts, a study found. U.S. veterans who visited a primary care clinician for low back pain were less likely to be prescribed opioids in the next year if they received chiropractic care, a recent study found.
-
1 month ago |
immattersacp.org | Charlotte Huff |Gianna Melillo |ACP Internist
https://immattersacp.org/weekly/archives/2025/05/27/2.htm I.M. Matters Weekly | Low back pain | May 27, 2025 U.S. veterans who visited a primary care clinician for low back pain were less likely to be prescribed opioids in the next year if they received chiropractic care, a recent study found. Patients with low back pain may be less likely to be prescribed opioids in the future if they receive chiropractic care, according to a recent study.
-
1 month ago |
immattersacp.org | Charlotte Huff |Gianna Melillo |ACP Internist
https://immattersacp.org/weekly/archives/2025/05/27/6.htm I.M. Matters Weekly | Diabetes | May 27, 2025 ACP critically reviewed current diabetes performance measures and found that only four of 14 commonly used indicators meet standards for quality and evidence-based care.
-
1 month ago |
immattersacp.org | Charlotte Huff |Gianna Melillo |ACP Internist
Digital breast tomosynthesis reduced recall rates and increased specificity compared to digital mammography screening in women with a relative with breast cancer, a study found. To compare the performance of the two screening modes in women with a family history of breast cancer, researchers conducted a comparative cohort study at imaging facilities affiliated with the Breast Cancer Surveillance Consortium from 2011 to 2018.
-
1 month ago |
immattersacp.org | Charlotte Huff |Gianna Melillo |ACP Internist
As-needed use of albuterol-budesonide resulted in lower risk of severe asthma exacerbations among patients whose condition was uncontrolled despite treatment for mild asthma, according to an industry-supported study. To examine the efficacy and safety of adding budesonide to albuterol for as-needed therapy, researchers funded by AstraZeneca conducted a phase 3b, multicenter trial between September 2022 and August 2024.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →